Resolution of inflammation: A new paradigm for the pathogenesis of periodontal diseases

Journal of Dental Research

Volumn 82, Issue 2, 2003, Pages 82-90

  Van Dyke, T E ^a   Serhan, C N ^b  

^a BOSTON UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Lipid mediators of inflammation; Lipoxins; Neutrophils; Periodontal disease

Indexed keywords

ACETYLSALICYLIC ACID; ALOX15B PROTEIN, HUMAN; ARACHIDONATE 15 LIPOXYGENASE; AUTACOID; HYDROXYICOSATETRAENOIC ACID; LEUKOTRIENE; LIPOXIN; LIPOXIN A; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN;

ANIMAL; BIOSYNTHESIS; DRUG EFFECT; HUMAN; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE ACTIVATION; METABOLISM; NEUTROPHIL; PERIODONTITIS; PHYSIOLOGY; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONATE 15-LIPOXYGENASE; ASPIRIN; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOTRIENES; LIPOXINS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PERIODONTITIS; PROSTAGLANDINS;

EID: 0037315708     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910308200202     Document Type: Short Survey

References (89)

1. Altman LC, Baker C, Fleckman P, Luchtel D, Oda D (1992). Neutrophil-mediated damage to human gingival epithelial cells. J Periodontal Res 27:70-79.
2. Ambrosio G, Tritto I (1999). Reperfusion injury: experimental evidence and clinical implications. Am Heart J 138:S69-S75.
3. 2-like' cells in allergy and asthma: pharmacological perspectives. Trends Pharmacol Sci 5:324-332.
4. 4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor. Proc Natl Acad Sci USA 86:3438-3442.
5. Badwey JA, Karnovsky ML (1980). Active oxygen species and the functions of phagocytic leukocytes. Ann Rev Biochem 49:695-726.
6. 4 accelerate resolution of allergic edema in Angiostrongylus costaricensis infected rats: relationship with concurrent eosinophilia. J Immunol 164:1029-1036.
7. Baumann H, Gauldie J (1994). The acute phase response. Immunol Today 15:74-80.
8. Brady HR, Serhan CN (1992). Adhesion promotes transcellular leukotriene biosynthesis during neutrophil-glomerular endothelial cell interactions: inhibition by antibodies against CD18 and L-selectin. Biochem Biophys Res Commun 186:1307-1314.
9. Brezinski ME, Serhan CN (1990). Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids. Proc Natl Acad Sci USA 87:6248-6252.
10. 4. Impact of aspirin therapy. Circulation 86:56-63.
11. Chavis C, Chanez P, Vachier I, Bousquet I, Michel FB, Godard P (1995). 5-15-diHETE and lipoxins generated by neutrophils from endogenous arachidonic acid as asthma biomarkers. Biochem Biophys Res Commun 207:273-279.
12. Chavis C, Vachier I, Chanez P, Bousquet I, Godard P (1996). 5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors. J Exp Med 183:1633-1643.
13. 4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. J Pharmacol Exp Ther 287:779-790.
14. 4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. J Clin Invest 104:309-316.
15. 4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J Exp Med 191:1197-1208.
16. Clària J, Serhan CN (1995). Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 92:9475-9479.
17. Clària J, Lee MH, Serhan CN (1996). Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol Med 2:583-596.
18. Clish CB, O'Brien JA, Gronert K, Stahl GL, Petasis NA, Serhan CN (1999). Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc Natl Acad Sci USA 96:8247-8252.
19. Colgan SP, Serhan CN, Parkos CA, Delp-Archer C, Madara JL (1993). Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J Clin Invest 92:75-82.
20. Corey EJ, Mehrotra MM (1986). A stereoselective and practical synthesis of 5,6 (S,S)-epoxy-15(S)-hydroxy-7 (E), 11(Z), 13(E)-eicosatetraenoic acid (4), possible precursor of the lipoxins. Tetrahedron Lett 27:5173-5176.
21. Cronstein BN, Montesinos MC, Weissmann G (1999a). Sites of action for future therapy: an adenosine-dependent mechanism by which aspirin retains its antiinflammatory activity in cyclooxygenase-2 and NFkappaB knockout mice. Osteoarthritis Cartilage 7:361-363.
22. Cronstein BN, Montesinos MC, Weissmann G (1999b). Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc Natl Acad Sci USA 96:6377-6381.
23. Dahlén SE, Serhan CN (1991). Lipoxins: bioactive lipoxygenase interaction products. In: Lipoxygenases and their products. Wong A, Crooke ST, editors. San Diego: Academic Press, p. 235.
24. de Waal Malefyt R (1999). Role of interleukin-10, interleukin-4, and interleukin-13 in resolving inflammatory responses. In: Inflammation: basic principles and clinical correlates. Gatlin I, Snyderman R, Fearon DT, Haynes BF, Nathan C, editors. Philadelphia: Lippincott Williams & Wilkins, p. 837.
25. Deguchi S, Hori T, Creamer H, Gabler W (1990). Neutrophil-mediated damage to human periodontal ligament-derived fibroblasts: role of lipopolysaccharide. J Periodontal Res 25:293-299.
26. Diamond P, McGinty A, Sugrue D, Brady HR, Godson C (1999). Regulation of leukocyte trafficking by lipoxins. Clin Chem Lab Med 37:293-297.
27. Edenius C, Kumlin M, Björk T, Anggard A, Lindgren JA (1990). Lipoxin formation in human nasal polyps and bronchial tissue. FEBS Lett 272:25-28.
28. Edenius C, Stenke L, Lindgren A (1991). On the mechanism of transcellular lipoxin formation in human platelets and granulocytes. Eur J Biochem 199:401-409.
29. Entman ML, Smith CW (1994). Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res 28:1301-1311.
30. 4. J Pharmacol Exp Ther 300:385-392.
31. 4 receptor. J Exp Med 180:253-260.
32. Gallin JI, Snyderman R, Fearon DT, Haynes BF, Nathan C, editors (1999). Inflammation: basic principles and clinical correlates. Philadelphia: Lippincott Williams & Wilkins.(AQ)
33. Gasic AC, McGuire G, Krater S, Farhood AI, Goldstein MA, Smith CW, et al. (1991). Hydrogen peroxide pretreatment of perfused canine vessels induces ICAM-1 and CD18-dependent neutrophil adherence. Circulation 84:2154-2166.
34. 4 analogs. J Clin Invest 101:1860-1869.
35. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, et al. (1995). Aspirin and the risk of colorectal cancer in women. N Engl J Med 333:609-614.
36. Godson C, Brady HR (2000). Lipoxins: novel anti-inflammatory therapeutics? Curr Opin Investig Drugs 1:380-385.
37. Golino P, Ragni M, Cirillo P, Avvedimento VE, Feliciello A, Esposito N, et al. (1996). Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med 2:35-40.
38. 4 and regulation of vascular and inflammatory responses. Am J Pathol 158:3-9.
39. Hachicha M, Pouliot M, Petasis NA, Serhan CN (1999). Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. J Exp Med 189:1923-1930.
40. Hansen PR (1995). Role of neutrophils in myocardial ischemia and reperfusion. Circulation 91:1872-1885.
41. Hennekens CH, Jonas MA, Bunng JE (1994). The benefits of aspirin in acute myocardial infarction. Still a well-kept secret in the United States. Arch Intern Med 154:37-39.
42. Herschman HR (1996). Prostaglandin synthase 2. Biochim Biophys Acta 1299:125-140.
43. Herschman HR (1998). Recent progress in the cellular and molecular biology of prostaglandin synthesis. Trends Cardiovasc Med 8:145-150.
44. Jordan JE, Zhao ZQ, Vinten-Johansen J (1999). The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43:860-878.
45. Katoh T, Lakkis FG, Makita N, Badr KF (1994). Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNA in rat nephrotoxic nephritis. Kidney Int 46:341-394.
46. L'Heureux GP, Bourgoin S, Jean N, McColl SR, Naccache PH (1995). Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GROalpha, stimulates phospholipase D activity. Blood 85:522-531.
47. Lakshman R, Finn A (2001). Neutrophil disorders and their management. J Clin Pathol 54:7-19.
48. 4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Clin Sci 77:195-203.
49. 4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am Rev Respir Dis 141:1453-1458.
50. 4: structure-function relationships. Biochem Biophys Res Commun 180:1416-1421.
51. 4: comparison of icosanoids having bronchoconstrictor and vasodilator actions but lacking platelet aggregatory activity. Proc Natl Acad Sci USA 85:8340-8344.
52. Levy BD, Romano M, Chapman HA, Reilly JJ, Drazen I, Serhan CN (1993a). Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5, 8, 11-cis-13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest 92:1572-1579.
53. 4-ELISA. Lipids 28:1047-1053.
54. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN (2001). Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2:612-619.
55. Levy GN (1997). Prostaglandin H synthases, nonsteroidal antiinflammatory drugs, and colon cancer. FASEB J 11:234-247.
56. 4 transfer. Trends Pharmacol Sci 14:351-354.
57. 4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin analogs with increased biologic activity. FASEB J 12:487-494.
58. Marcus AJ (1995). Aspirin as prophylaxis against colorectal cancer. N Engl J Med 333:656-658.
59. Malaviya R, Abraham SN (2000). Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J Leukoc Biol 67:841-846.
60. Nassar GM, Morrow JD, Roberts LJ 2nd, Lakkis FG, Badr KF (1994). Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem 269:27631-27634.
61. 4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis. Kidney Int 47:1295-1302.
62. 4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J Immunol 56:2264-2272.
63. Pouliot M, McDonald PP, Borgeat P, McColl SR (1994). Granulocyte/ macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J Exp Med 79:1225-1232.
64. 4 up-regulate transcriptional corepressor NAB 1 in human neutrophils. FASEB J 15:2736-2738.
65. Ring WL, Riddick CA, Baker JR, Munafo DA, Bigby TD (1996). Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein in monocytes in vitro via granulocyte macrophage colony-stimulating factor and interleukin 3. J Clin Invest 97:1293-1301.
66. Samuelsson B (1982). In: Les Prix Nobel: Nobel prizes, presentations, biographies and lectures. Stockholm: Almqvist & Wiksell, p. 153.
67. Samuelsson B, Dahlén SE, Lindgren JA, Rouzer CA, Serhan CN (1987). Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237:1171-1176.
68. Savage MP, Goldberg S, Bove AA, Deutsch E, Vetrovec G, Macdonald RG, et al. (1995). Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multiple-hospital Eastern Atlantic Restenosis Trial (M-HEART II). Circulation 92:3194-3260.
69. Serhan CN (1994). Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim Biophys Acta 1212:1-25.
70. Serhan CN (1997). Lipoxins and novel aspirin-triggered 15-epilipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins 53:107-137.
71. Serhan CN, Prescott SM (2000). The scent of a phagocyte: advances on leukotriene b(4) receptors. J Exp Med 192:F5-F8.
72. 4 by platelet 12-lipoxygenase in vitro. J Clin Invest 85:772-780.
73. Serhan CN, Hamberg M, Samuelsson B (1984). Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci USA 81:5335-5339.
74. 4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34:14609-14615.
75. Serhan CN, Haeggstrom JZ, Leslie CC (1996). Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J 10:1147-1158.
76. 4. J Immunol 166:3650-3654.
77. Serhan C, Jain A, Stahl G, Van Dyke TE (2002). 15-Lo transgenic and lipoxin analogs block tissue damage in inflammatory disease. J Exp Med (manuscript in preparation).
78. Shapira L, Borinski R, Sela MN, Soskolne A (1991). Superoxide formation and chemiluminescence of peripheral polymorphonuclear leukocytes in rapidly progressive periodontitis patients. J Clin Periodontol 18:44-48.
79. Shen J, Herderick E, Cornhill JF, Zsigmond E, Kim HS, Kuhn H, et al. (1996). Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 98:2201-2208.
80. Sigal E, Conrad DJ (1994). Human 15-lipoxygenase: a potential effector molecule for interleukin-4. Adv Prostaglandin Thromboxane Leukot Res 22:309-316.
81. 4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinases 3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol 164:2660-2666.
82. Stenke L, Reizenstein P, Lindgren JA (1994). Leukotrienes and lipoxins - new potential performers in the regulation of human myelopoiesis. Leuk Res 18:727-732.
83. 4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med 185:1693-1704.
84. 4 stable analogues. J Clin Invest 101:819-826.
85. Thomas E, Leroux JL, Blotman F, Chavis C (1995). Conversion of endogenous arachidonic acid to 5,15-diHETE and lipoxins by polymorphonuclear cells from patients with rheumatoid arthritis. Inflamm Res 44:121-124.
86. Van Dyke TE, Zinney W, Winkel K, Taufiq A, Offenbacher S, Arnold RR (1986). Neutrophil function in localized juvenile periodontitis. Phagocytosis, superoxide production and specific granule release. J Periodontol 57:703-708.
87. Vane JR (1982). Adventures and excursions in bioassay: the stepping stones to prostacyclin. In: Les Prix Nobel: Nobel prizes, presentations, biographies and lectures. Stockholm: Almqvist & Wiksell, p. 181.
88. Varani J, Ward PA (1994). Mechanism of neutrophil-dependent and neutrophil-independent endothelial cell injury. Biol Signals 3:1-14.
89. Weiss SJ (1989). Tissue destruction by neutrophils. N Engl J Med 320:365-376.